Skip to content
Search AI Powered

Latest Stories

An Incredibly Deadly Virus That Emerged in the 1990s Just Had an Outbreak in India

An Incredibly Deadly Virus That Emerged in the 1990s Just Had an Outbreak in India
Animal Husbandry department and Forest officials deposit a bat into a container after catching it inside a well at Changaroth in Kozhikode in the Indian state of Kerala on May 21, 2018. - A deadly virus carried mainly by fruit bats has killed at least three people in southern India, sparking a statewide health alert May 21. Eight other deaths in the state of Kerala are being investigated for possible links to the Nipah virus, which has a 70 percent mortality rate. (Photo by - / AFP) (Photo credit should read -/AFP/Getty Images)

But the medical and biotech communities are already responding.

The most feared viruses are those for which medical science has not yet developed a treatment, cure or preventive vaccine. Often, such viral agents have only been recently discovered and emerged as an outbreak in a particular region of the world. This is the case for the Nipah virus (NiV), which has claimed the lives of at least nine people in India this year.

Nipah virus was first discovered in Malaysia in the late 1990s when an outbreak of the virus struck approximately 265 people. People became sick after physically interacting with pigs in the area, with symptoms manifesting as brain inflammation.


Of the 265 that contracted the disease, 105 lost their lives. The fatality rate jumped from 40% to 75% with subsequent outbreaks, which took place in Bangladesh and India. Authorities followed established protocols for containing the zoonotic disease, a contagion spread from animals to humans, through the culling of the apparent host species: pigs.

The impact of these actions was moderate as it was determined that NiV could not only transmit from pigs to humans, but also that person-to-person transmission was possible.

Later investigations identified two species of sizable fruit bats also known as “large flying foxes” and “small flying foxes” as the natural host reservoirs for the Nipah virus.

The course of infection in humans begins with disorientation, drowsiness and headaches, which progresses to influenza-like symptoms including: general weakness, fever, nausea, vomiting, pain in the abdomen, followed by eventual encephalitis. The most severe cases see a combination of acute encephalitis and seizures. Despite the absence of any medical treatments for the disease, people can survive infection with NiV, though they are often left with neurological disorders marked by aberrations in personality and recurrent seizures.

During the preparation of this article, health officials in India declared that the “highly dangerous phase” of the recent 2018 NiV outbreak was over. This conclusion was reached after no new cases of human infection were reported in more than two weeks after the initial flare-up of the disease in India. By this point, a “second phase” of new NiV infections were anticipated based on previous outbreaks, but this has not transpired. The number of cases had advanced to 18 of which 16 of the patients had died due to NiV. The two remaining NiV-infected individuals were responding well to treatment with Ribavirin, a potent anti-viral drug. Both were reported to be virus-free, though a decision has yet to be reached on when to discharge them.

Beyond this current, apparently contained, NiV outbreak in India, should there be greater global concern about this virus? Both the United States Centers for Disease Control (CDC) and the World Health Organization (WHO) have classified NiV as a pathogen that has the potential to become a pandemic agent. A pathogen that can cause a pandemic is one that has a high level of communicability among people to spread across the globe in a relatively short amount of time. For example, it took just months for the H1N1 influenza epidemic of 2009 to reach pandemic status. Fortunately, in that instance, the lethality of the virus was less than what was anticipated.

In light of the recent NiV outbreak, a virus that the WHO ranks in its top priorities alongside Ebola virus and Zika virus, a global health consortium called the Coalition for Epidemic Preparedness Innovations (or CEPI) awarded 25 million dollars to biotech companies in the United States that have been leading the charge to develop a NiV vaccine.

There are at least two different experimental NiV vaccines that have shown protective results when tested in animal models. One vaccine candidate involves a recombinant vesicular stomatitis virus (VSV) decorated with the immunogenic glycoprotein of NiV. VSV is a well-studied virus that has been attenuated in the laboratory setting and has been investigated for its capacity to be genetically altered to have its surface coated with immune system stimulating molecules from a variety of different viruses. The VSV-NiV vaccine offered protection from NiV infection in African Green Monkeys after a single-dose.

A virus-like particle (VLP) derived from the actual Nipah virus is the basis of another vaccine candidate. Scientists were able to produce a VLP that was structurally similar the natural virus but was composed of only three of the NiV proteins. These proteins self-assembled into a virus particle that should be as immunogenic as NiV. This approach has advantages for when it comes time for regulatory agencies to approve its use on humans, since the VLP lacks the biological components necessary for replication and therefore is incapable of mutating and producing new virus when administered to a person. When tested in hamsters, both single-dose and triple-dose regimens offered complete protection against NiV.).

Finally, there is one possible therapeutic approach to treating individuals already infected with NiV. A special antibody has been developed by scientists at the University of Queensland in Australia. The antibody, called M-102.4, has yet to be patented and has not been clinically tested in humans. However, in the laboratory, M-102.4 has proven effective in neutralizing NiV in infected cells. The antibody has been shipped to India as a possible treatment for NiV-infected individuals should the current outbreak flare up again or in the event of the emergence of NiV in another region.

The recent developments of the aforementioned vaccine platforms and the antibody therapeutic offer some hope in the battle against Nipah virus around the globe. However, until there is a vaccine, a cure and treatments that have been clinically tested and verified in humans, detection and containment procedures will be the best defense against this virus that has the potential to spread worldwide.

More from News

Ribvar Karimi and Morgan Gardner Karimi
Morgan Karimi/Facebook

Alabama Woman 'Blindsided' After ICE Detains Her Trump-Supporting Iranian Husband

Another day, another MAGA face eaten by a leopard.

The "it wasn't supposed to happen to me" movement claimed two more victims on Sunday, June 22, when Ribvar Karimi was abducted by the Department of Homeland Security's (DHS's) Immigration and Customs Enforcement (ICE) agents in a sweep that included 11 Iranians.

Keep ReadingShow less
Robert F. Kennedy Jr.
Alex Wong/Getty Images

RFK Jr. Admits That Banning Fluoridated Water Will Cause 'More Cavities'—But He's OK With That

Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. was criticized after admitting in a Fox News interview with Harris Faulkner that his proposed fluoridated water ban would likely lead people to have more cavities—but defended the move nonetheless.

While fluoride is not federally mandated in drinking water, the Centers for Disease Control and Prevention (CDC) had long recommended its inclusion. Fluoride helps prevent cavities by strengthening enamel, and numerous studies have shown that fluoridated water reduces tooth decay in both children and adults.

Keep ReadingShow less
Screenshot of Jesse Watters discussing Zohran Mamdani
Fox News

Jesse Watters Dragged After Trying To Give Mamdani A Scary Nickname That's Actually Kind Of Epic

Fox News personality Jesse Watters was widely mocked after he tried to give New York City mayoral candidate Zohran Mamdani a scary nickname in the vein of Conan the Destroyer—only for it to backfire considerably.

Watters is the latest member of the GOP to lash out at Mamdani, a democratic socialist who handily defeated former New York Governor Andrew Cuomo in New York City's Democratic mayoral primary last week.

Keep ReadingShow less
A man sitting on a couch
man sitting on sofa
Photo by Kelly Sikkema on Unsplash

People Sound Off On What Caused Them To Fire Their Therapist

We thankfully live in a world where there's no longer a stigma surrounding therapy.

Some people simply need professional help to deal with ongoing problems or even to get through the day.

Keep ReadingShow less
Andy Ogles; Zohran Mamdani
Michael M. Santiago/Getty Images (left and right)

MAGA Rep Slammed After Calling For Mamdani To Be Stripped Of His Citizenship And Deported Over Rap Lyric

Tennessee Republican Andy Ogles was called out after he shared a letter he sent to Attorney General Pam Bondi urging her to denaturalize and deport New York City mayoral candidate Zohran Mamdani over a lyric in a rap song Mamdani released in 2017.

Mamdani ran a campaign centered around economic populism, arguing that the city, a global financial center, has grown unaffordable for everyday residents, citing soaring rents and grocery prices, and outlining policies aimed at reducing the cost of living.

Keep ReadingShow less